Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorder

AIDS Reader

Volumn 17, Issue 12, 2007, Pages

  Yates, Jennifer A ^a   Zakai, Neil A ^b   Griffith, Rogers C ^c   Wing, Edward J ^d   Schiffman, Fred J ^d  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c BROWN UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Castleman disease; Epstein Barr virus; Hepatitis C; HIV AIDS; Human herpesvirus 8; Immune reconstitution inflammatory syndrome; Kaposi sarcoma; Lymphoma; Lymphoproliferative disorder

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE; GANCICLOVIR; LOPINAVIR; PREDNISONE; RITONAVIR; TENOFOVIR;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; FATIGUE; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; OPPORTUNISTIC INFECTION; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; WEIGHT REDUCTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; DIAGNOSIS, DIFFERENTIAL; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; LYMPH NODES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; SARCOMA, KAPOSI;

EID: 37249078151     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406-1412.
2. Du M, Diss TC, Liu H, et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2002;100:3415-3418.
3. Scadden DT, Muse VV, Hasserjian RP. Case records of the Massachusetts General Hospital. Case 30-2006: a 41-year-old man with dypsnea, fever and lymphadenopathy. N Engl J Med. 2006;355:1358-1368.
4. Aboulafia DM, Picozzi VJ, Patterson S. Castleman's disease, Kaposi's sarcoma and immunoblastic lymphoma in a patient with AIDS. AIDS Reader. 1998;8:107-113.
5. Seliem RM, Griffith RC, Harris NL, et al. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Am J Surg Pathol. 2007;31:1439-1445.
6. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86:1276-1280.
7. Casper C, Nichols WG, Huang M, et al. Remission of HHV-8 and HIV-associated multicentric Castleman's disease with ganciclovir treatment. Blood. 2004;103:1632-1634.
8. Leao JC, Kumar N, McLean KA, et al. Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-1-infected patients. J Med Virol. 2000;62:416-420.
9. Newsom-Davis T, Bower M, Wildfire A, et al. Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels. Leuk Lymphoma. 2004;45:1939-1941.
10. Marcelin AG, Aaron L, Mateus C, et al. Rituximab therapy for HIV-associated Castleman disease. Blood. 2003;102:2786-2788.
11. Lerza R, Castello G, Truini M, et al. Splenectomy induced complete remission in a patient with multicentric Castleman's disease and autoimmune hemolytic anemia. Ann Hematol. 1999;78:193-196.
12. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989;74:1360-1367.
13. Staskus KA, Sun R, Miller G, et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol. 1999;73:4181-4187.
14. Waterston A, Bower M. Fifty years of multicentric Castleman's disease. Acta Oncol. 2004;43:698-704.
15. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723-1732.
16. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94.
17. Gérard L, Bérezné A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol. 2007;25:3350-3356.
18. Scadden DT, Muse VV, Hasserjian RP. Case records of the Massachusetts General Hospital. Case 30-2006: a 41-year-old man with dypsnea, fever and lymphadenopathy. N Engl J Med. 2006;355:1358-1368.
19. Seliem RM, Griffith RC, Harris NL, et al. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Am J Surg Pathol. 2007;31:1439-1445.
20. Gérard L, Bérezné A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol. 2007;25:3350-3356.